Accelerating Drug Development with Innovative Services
Epistem is a leading company providing innovative services to accelerate drug development programs. We provide preclinical and clinical services that can either be classified by technique or by therapeutic area 



Epistem is a leading specialist preclinical contract research organisation offering Preclinical models and lab test services providing valuable support to drug discovery programs and development pipelines.

Clinical Trials

Biotechnology

Epistem

Cath Booth

James Wilson

Adam Boanas

James Fullerton-Batten

Andrew Edwards

Julie Tudor

The Leadership Team at Epistem, comprising the CEO, CFO, and Principal Scientist, is responsible for steering the company's strategic direction, managing financial operations, and overseeing scientific research and development to support and enhance drug discovery programs.

Leadership Team

Scientists Team

Business Development and Marketing

Leadership Team

About

Team members

Other teams at Epistem

Scientists Team

Business Development and Marketing